Research map: The Optimal Lung Cancer Ct Screening Strategy: A Cost‐Effectiveness Study Incorporating Nelson Evidence, Evolving Cost of Treatment and Smoking Cessation Interventions

Back to the article

Papers in this map

  1. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening · The National Lung Screening Trial Research Team · 2011 · 11268 citations · Cited by this paper
  2. Helicobacter pylori Infection and the Risk of Biliary Tract and Pancreatic Cancers: Subsite‐Specific Associations in a Japanese Population · 2026 · Related
  3. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial · Harry J. de Koning · 2020 · 3676 citations · Cited by this paper
  4. Sodium‐Glucose Cotransporter 2 Inhibitors and Cancer Risk in Patients With Type 2 Diabetes Mellitus: An Active Comparator, New‐User Cohort Study · 2026 · Related
  5. Screening for Lung Cancer · US Preventive Services Task Force · 2021 · 1828 citations · Cited by this paper
  6. Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma · 2026 · Related
  7. The Effect of Advances in Lung-Cancer Treatment on Population Mortality · Nadia Howlader · 2020 · 1798 citations · Cited by this paper
  8. The Circulating Cholangiocarcinoma Protein Biomarkers CRP and MASP2 Also Predict Gallbladder Cancer Risk · 2026 · Related
  9. Selection Criteria for Lung-Cancer Screening · Martin Carl Tammemägi · 2013 · 1046 citations · Cited by this paper
  10. Obesity‐Driven Early‐Onset Colorectal Cancer: Mechanistic Insights and Emerging Clinical Implications · 2026 · Related
  11. Self-Reported Population Health: An International Perspective based on EQ-5D · Ágota Szende · 2013 · 807 citations · Cited by this paper
  12. Changing the History of Science—An Editorial Perspective on Critical Developments in Current Citation Practice, “Forgetting” the Pioneers of Scientific Discoveries · 2026 · Related
  13. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening · Nanda Horeweg · 2014 · 538 citations · Cited by this paper
  14. Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very‐High‐Risk and High‐Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety · 2026 · Related
  15. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations · Don Husereau · 2022 · 488 citations · Cited by this paper
  16. Neoadjuvant Chemotherapy Versus Upfront Surgery for cT2N1 or cT3a ‐ bN0 ‐1 Middle‐High Rectal Cancer · 2026 · Related
  17. Advances in systemic therapy for non-small cell lung cancer · Meagan Elizabeth Miller · 2021 · 397 citations · Cited by this paper
  18. HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer · 2026 · Related
  19. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers · Nanda Horeweg · 2014 · 391 citations · Cited by this paper
  20. Future Trends in Cancer Prevention and Interception in Cancer Predisposition Syndromes: Leveraging Insights From High‐Risk Populations · 2026 · Related
  21. Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts · Martin Carl Tammemägi · 2014 · 367 citations · Cited by this paper
  22. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada · Kevin ten Haaf · 2017 · 141 citations · Cited by this paper
  23. European cancer mortality predictions for the year 2023 with focus on lung cancer · Matteo Charles Malvezzi · 2023 · 133 citations · Cited by this paper
  24. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen · Nicola Sverzellati · 2016 · 118 citations · Cited by this paper
  25. Analysis of lung cancer incidence in the nurses’ health and the health professionals’ follow-up studies using a multistage carcinogenesis model · Rafael Arturo Meza · 2007 · 100 citations · Cited by this paper
  26. Lung cancer screening and smoking cessation efforts · Dana Moldovanu · 2021 · 83 citations · Cited by this paper
  27. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening · Iakovos Toumazis · 2021 · 68 citations · Cited by this paper
  28. Risk Model–Based Lung Cancer Screening · Iakovos Toumazis · 2023 · 67 citations · Cited by this paper
  29. Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis · Christopher J. Cadham · 2019 · 50 citations · Cited by this paper
  30. Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography · Helen Grover · 2022 · 47 citations · Cited by this paper
  31. Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer · Erik F. Blom · 2020 · 42 citations · Cited by this paper
  32. Strategies to deliver smoking cessation interventions during targeted lung health screening - a systematic review and meta-analysis · Parris Jade Williams · 2023 · 37 citations · Cited by this paper
  33. Lung cancer screening: where do we stand? · Georgia Hardavella · 2024 · 31 citations · Cited by this paper
  34. Implementation of the NHS England Lung Cancer Screening Programme over 5 years · Richard W. Lee · 2026 · 28 citations · Cited by this paper
  35. Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening Guidelines · Kine Pedersen · 2023 · 21 citations · Cited by this paper
  36. Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012–2021) · Koen de Nijs · 2024 · 18 citations · Cited by this paper
  37. Cost‐effectiveness of risk‐based low‐dose computed tomography screening for lung cancer in Switzerland · Yuki Tomonaga · 2023 · 17 citations · Cited by this paper
  38. Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands · Emilie C. H. Breekveldt · 2022 · 16 citations · Cited by this paper
  39. Projected effectiveness of lung cancer screening and concurrent smoking cessation support in the Netherlands · Koen de Nijs · 2024 · 16 citations · Cited by this paper

Source: OpenAlex (CC0)